Deborah Gouveia

Deb Gouveia joined Triplet Therapeutics, Inc. as Vice President, Clinical Operations in September 2020. She has more than 25 years of experience in global pharmaceutical development and operations. Deb previously served as VP, Clinical Operations at Angion, where she played a critical role in establishing the clinical operations function and supporting both early and late-stage clinical programs. Prior to that, she held multiple senior leadership positions in clinical operations, clinical development, program management, and regulatory affairs across several companies including Stealth Biotherapeutics, Atreaon, MGI Pharma and Logical Therapeutics. Her experience spans across many therapeutic areas including Cardiorenal, Oncology, Infectious disease and Orphan/Rare disease. Deb holds a BS in Biology from the University of Massachusetts.